With the FDA approval of two CAR-T cell-based therapies, chimeric antigen receptor (CAR)-engineered T cell therapy becomes more and more popular in academic and clinical application. Based on the outstanding expertise and rich experience, Creative Biolabs has specially developed a comprehensive platform for CAR-T cell-based drug discovery. This platform enables us to offer GMP-level plasmid preparation, virus packaging, and T cell production services to help you discover new therapies. GMP production for CAR-T products https://www.creative-biolabs.com/car-t/gmp-production-for-car-t-products.htm
Le contenu envoyé sera déplacé vers cet album nouvellement créé. Vous devez créer un compte ou se connecter si vous souhaitez modifier cet album plus tard.